Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Docetaxel - Accord

Next Previous
Drug Profile

Docetaxel - Accord

Alternative Names: AXTERE; TAXANIT; TAXOCCORD

Latest Information Update: 18 Dec 2021

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Accord Healthcare
  • Class Antineoplastics; Small molecules; Taxanes
  • Mechanism of Action Mitosis inhibitors; Tubulin modulators; Tubulin polymerisation promoters
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Breast cancer; Gastric cancer; Head and neck cancer; Non-small cell lung cancer; Oesophageal cancer; Prostate cancer
  • Registered Colorectal cancer; Ovarian cancer

Most Recent Events

  • 08 Aug 2017 Registered for Colorectal cancer in Mexico (IV) (Accord Healthcare website, August 2017) before August 2017
  • 15 Jul 2015 Registered for Breast cancer (Combination therapy, Adjunctive treatment, Metastatic disease) in Mexico (IV)
  • 15 Jul 2015 Registered for Head and neck cancer (Combination therapy, Inoperable/Unresectable) in Mexico (IV)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top